4.6 Article

Digital cognitive behavioral therapy for insomnia promotes later health resilience during the coronavirus disease 19 (COVID-19) pandemic

Journal

SLEEP
Volume 44, Issue 4, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/sleep/zsaa258

Keywords

stress; COVID-19; insomnia; depression; CBT-I; engagement; prevention; primary care; digital health

Funding

  1. National Heart Lung and Blood Institute [K23HL138166]

Ask authors/readers for more resources

This study found that individuals with a history of insomnia who previously received digital cognitive-behavioral therapy for insomnia (dCBT-I) showed increased health resilience during the COVID-19 pandemic, with reduced insomnia symptoms, stress, and depression, and improved overall health. These results suggest that dCBT-I can be a powerful tool for promoting mental and physical health during stressful events like the COVID-19 pandemic.
Study Objectives Stressful life events contribute to insomnia, psychosocial functioning, and illness. Though individuals with a history of insomnia may be especially vulnerable during stressful life events, risk may be mitigated by prior intervention. This study evaluated the effect of prior digital cognitive-behavioral therapy for insomnia (dCBT-I) versus sleep education on health resilience during the COVID-19 pandemic. Methods COVID impact, insomnia, general- and COVID-related stress, depression, and global health were assessed in April 2020 in adults with a history of insomnia who completed a randomized controlled trial of dCBT-I (n = 102) versus sleep education control (n = 106) in 2016-2017. Regression analyses were used to evaluate the effect of intervention conditions on subsequent stress and health during the pandemic. Results Insomnia symptoms were significantly associated with COVID-19 related disruptions, and those who previously received dCBT-I reported less insomnia symptoms, less general stress and COVID-related cognitive intrusions, less depression, and better global health than those who received sleep education. Moreover, the odds for resurgent insomnia was 51% lower in the dCBT-I versus control condition. Similarly, odds of moderate to severe depression during COVID-19 was 57% lower in the dCBT-I condition. Conclusions Those who received dCBT-I had increased health resilience during the COVID-19 pandemic in adults with a history of insomnia and ongoing mild to moderate mental health symptoms. These data provide evidence that dCBT-I is a powerful tool to promote mental and physical health during stressors, including the COVID-19 pandemic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available